Skip to main content
Ted Feldman, MD, Cardiology, Irvine, CA, NorthShore University Health System

TedEFeldmanMD

Cardiology Irvine, CA

Adult Congenital Heart Disease, Cardiac Electrophysiology, Interventional Cardiology

Physician

Dr. Feldman is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Feldman's full profile

Already have an account?

Education & Training

  • University of Chicago Medical Center
    University of Chicago Medical CenterFellowship, Cardiovascular Disease, 1982 - 1985
  • Rush University Medical Center
    Rush University Medical CenterResidency, Internal Medicine, 1978 - 1982
  • Indiana University School of Medicine
    Indiana University School of MedicineClass of 1978

Certifications & Licensure

  • OK State Medical License
    OK State Medical License 1987 - 1989
  • IL State Medical License
    IL State Medical License 1979 - 2023
  • IN State Medical License
    IN State Medical License 1978 - 2005
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Cardiovascular Disease

Awards, Honors, & Recognition

  • America's Top Doctors Castle Connolly, 2002-2014
  • Chicago Magazine: Top Doctors Castle Connolly, 2004, 2006, 2008, 2010, 2012, 2014
  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Lectures

  • SCAI 2012 Fall Fellows Courses 
    Society for Cardiovascular Angiography and Interventions, Las Vegas, Nevada - 12/5/2012

Press Mentions

  • Mechanically Expanded TAVR May Benefit High-Risk Aortic Stenosis Patients
    Mechanically Expanded TAVR May Benefit High-Risk Aortic Stenosis PatientsJanuary 9th, 2018
  • ESC: Interatrial Shunting Safe in HFpEF, Pivotal Trial to Come
    ESC: Interatrial Shunting Safe in HFpEF, Pivotal Trial to ComeAugust 27th, 2018
  • REPRISE III: Lotus Valve Matches CoreValve in First Head-to-Head TAVR Trial
    REPRISE III: Lotus Valve Matches CoreValve in First Head-to-Head TAVR TrialMay 16th, 2017
  • Join now to see all

Professional Memberships

Hospital Affiliations